found, in a relatively small Israelian cohort, CagA seropositivity to be strongly associated with an increased risk for not only gastric cancer (OR=88.1), as expected but also for CRC (OR=10.6) (Shmuely et al., 2001). This evidence concerns the gene S100A8 and colorectal carcinoma.